Search - tctmd.com

Displaying 21 - 40 of 134

Sort: Relevancy | Date

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Recent EU Clinical Experiences with the ACURATE TAVR System

Presenter: Ole De Backer

October 28, 2024

Presentation TCT 2024

ACURATE Fundamentals: What You Need to Know

Presenter: Srini Potluri

October 28, 2024

Presentation TCT 2024

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Presenter: Ignacio Amat-Santos

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Presenter: Jonathan Michel

June 07, 2024

Presentation NY Valves 2024

Understanding the Fundamentals of the ACURATE Platform

Presenter: Isaac George

June 05, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

TCT 261: Review of Short-term Outcomes of ACURATE neo2

Presenter: Akihiro Tobe

October 26, 2023

Presentation TCT 2023

ACURATE Case in a Box

Presenter: Ravi Ramana

October 25, 2023

Presentation TCT 2023

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

Presenter: Pradeep Yadav

October 25, 2023

Presentation TCT 2023

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

Presenter: Ahmed Elkoumy

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

News Daily News

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

Caitlin E. Cox

July 21, 2023

Presentation TVT 2023

Clinical Data for the ACURATE Platform

Presenter: Ole De Backer

June 08, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Comparing TAVI Devices: Much Overlap, Some Nuances to Guide Care

Caitlin E. Cox

December 19, 2022

Advertisement

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Recent EU Clinical Experiences with the ACURATE TAVR System

ACURATE Fundamentals: What You Need to Know

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

What’s Going to Be Big at TCT 2024?

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Understanding the Fundamentals of the ACURATE Platform

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

TCT 261: Review of Short-term Outcomes of ACURATE neo2

ACURATE Case in a Box

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

Clinical Data for the ACURATE Platform

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Comparing TAVI Devices: Much Overlap, Some Nuances to Guide Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content